Company Listing
Galapagos

Galapagos is a drug discovery company with small molecule programmes in a broad range of therapeutic areas. Galapagos was established in 1998 as a joint venture between Tibotec-Virco (acquired by Johnson & Johnson in March 2002) and Crucell. The company went public in May 2005.

BACK
Location
Mechelen, Belgium
Website Address

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Galapagos is a drug discovery company with small molecule programmes in a broad range of therapeutic areas. Galapagos was established in 1998 as a joint venture between Tibotec-Virco (acquired by Johnson & Johnson in March 2002) and Crucell. The company went public in May 2005.

Location
Mechelen, Belgium
Website Address
BACK
 
Copyright Abingworth 2017